A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes

NCT05144984 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: NNC0480-0389
DRUG: Semaglutide
DRUG: Placebo (NNC080-0389)
DRUG: Placebo (semaglutide)

Sponsor

Novo Nordisk A/S